Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system
- PMID: 25542054
- DOI: 10.1016/S0213-005X(14)70176-4
Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system
Abstract
There has been a rapid increase in recent years in the incidence of infection and colonization by carbapenemase-producing Enterobacteriaceae (CPE). A number of clusters and outbreaks have been reported, some of which have been contained, providing evidence that these clusters and outbreaks can be managed effectively when the appropriate control measures are implemented. This review outlines strategies recommended to control CPE dissemination both at the healthcare facility level (acute and long-term care) and from the public health point of view. A dedicated prepared plan should be required to prevent the spread of CPE at the hospital level. At the front line, activities should include management of patients at admission and new cases, active surveillance culturing and definition of high-risk groups. High compliance with standard precautions for all patients and full or modified contact precautions for defined categories of patients should be implemented. Long-term care facilities are areas where dissemination can also take place but more importantly they can become a reservoir as patients are admitted and released to other Health care facilities. From the public health point of view, surveillance must be tailored to identify regional spread and interfacility transmission to prevent further dissemination. Finally, a comprehensive set of activities at various levels is necessary to prevent further spread of these bacteria in the community.
Keywords: Carbapenemase-producing Enterobacteriaceae; Control de la infección; Enterobacterias productoras de carbapenemasas; Healthcare facilities; Hospital preparation plan; Infection control; Instituciones de crónicos; Instituciones sanitarias; Long-term care facilities; Plan de preparación para el hospital.
Copyright © 2014 Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:17-23. doi: 10.1016/S0213-005X(14)70170-3. Enferm Infecc Microbiol Clin. 2014. PMID: 25542048 Review.
-
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:41-8. doi: 10.1016/S0213-005X(14)70173-9. Enferm Infecc Microbiol Clin. 2014. PMID: 25542051 Review.
-
Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:1-3. doi: 10.1016/S0213-005X(14)70167-3. Enferm Infecc Microbiol Clin. 2014. PMID: 25542045
-
Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms.Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:10-6. doi: 10.1016/S0213-005X(14)70169-7. Enferm Infecc Microbiol Clin. 2014. PMID: 25542047 Review.
-
Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:49-55. doi: 10.1016/S0213-005X(14)70174-0. Enferm Infecc Microbiol Clin. 2014. PMID: 25542052 Review.
Cited by
-
Outbreak of KPC-producing Klebsiella pneumoniae at a Portuguese university hospital: Epidemiological characterization and containment measures.Porto Biomed J. 2022 Dec 1;7(6):e186. doi: 10.1097/j.pbj.0000000000000186. eCollection 2022 Nov-Dec. Porto Biomed J. 2022. PMID: 37152080 Free PMC article.
-
Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.Antimicrob Resist Infect Control. 2022 Jun 22;11(1):89. doi: 10.1186/s13756-022-01103-0. Antimicrob Resist Infect Control. 2022. PMID: 35733230 Free PMC article.
-
The use of multi-pronged screening strategy to understand the epidemiology of carbapenemase-producing Enterobacteriaceae in Hong Kong: transition from epidemic to endemic setting.Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):2017-2022. doi: 10.1007/s10096-021-04173-x. Epub 2021 Mar 5. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33666789
-
[Risk factors and clinical evolution of carbapenemase-producing Klebsiella pneumoniae infections in a university hospital in Spain. Case-control study].Rev Esp Quimioter. 2018 Oct;31(5):427-434. Epub 2018 Sep 18. Rev Esp Quimioter. 2018. PMID: 30229644 Free PMC article. Spanish.
-
Occurrence of Healthcare-Associated Infections (HAIs) by Escherichia coli and Klebsiella spp. Producing Extended-Spectrum β-lactamases (ESBL) and/or Carbapenemases in Portuguese Long-Term Care Facilities.Pathogens. 2022 Sep 7;11(9):1019. doi: 10.3390/pathogens11091019. Pathogens. 2022. PMID: 36145451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous